Information  X 
Enter a valid email address

Nostra Terra O&G Co (NTOG)

  Print      Mail a friend

Monday 11 March, 2019

Nostra Terra O&G Co

Confirmation of TVR & Notifiable Positions

RNS Number : 3824S
Nostra Terra Oil & Gas Company PLC
11 March 2019
 

11 March 2019

 

Nostra Terra Oil and Gas Company plc

("Nostra Terra" or the "Company")

 

Confirmation of TVR & Notifiable Positions

 

Further to the announcement of 07 March 2019, Nostra Terra confirms the current total voting rights of the Company is presently 147,206,221 ("TVR Today"). Following admission of the 47,916,665 new ordinary shares, announced in the placing on 27 February 2019 and which is expected to occur on 13 March 2019 ("Admission"), the Company's total voting rights is expected to increase to 195,122,886 ("TVR on 13 March").

 

For the sake of clarity the Company sets out below the notifiable positions of Miton Group Plc and Eridge Capital Limited on the basis of the TVR Today and the TVR on 13 March, following the allotment and issuance of shares to placees.

 

Shareholder

Holding of Ordinary Shares following Admission*

% of VR Today

% of VR on 13 March

Miton Group plc

19,791,666

0

10.14

Eridge Capital Limited

9,731,333

4.43

4.98

 

* Based on the latest information provided to the Company by the shareholders

 

For further information, visit www.ntog.co.uk or contact:

 

Nostra Terra Oil and Gas Company plc

Matt Lofgran, CEO

 

Tel:

+1 480 993 8933

Strand Hanson Limited

(Nominated & Financial Adviser and Joint Broker)

Rory Murphy / Ritchie Balmer / Jack Botros

 

Tel:

+44 (0) 20 7409 3494

Shard Capital Stockbrokers (Joint Broker)

Damon Heath / Erik Woolgar

 

Tel:

+44 (0) 207 186 9952

Smaller Company Capital Limited (Joint Broker)

Rupert Williams / Jeremy Woodgate

Tel:

+44 (0) 20 3651 2910




 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCURVKRKVAOAAR

a d v e r t i s e m e n t